Adherence, acceptability, and usability of a smartphone app to promote physical exercise in patients with peripheral arterial disease and intermittent claudication

被引:0
|
作者
Oliveira, Rafaela [1 ]
Pedras, Susana [1 ]
Veiga, Carlos [1 ]
Moreira, Luis [2 ]
Santarem, Daniel [2 ]
Guedes, Daniel [2 ]
Paredes, Hugo [2 ,3 ]
Silva, Ivone [1 ,4 ,5 ]
机构
[1] Ctr Hosp Univ Porto, Angiol & Vasc Surg Dept, Porto, Portugal
[2] Univ Tras Os Montes & Alto Douro, Dept Engn, Escola Ciencias & Tecnol, Vila Real, Portugal
[3] Inst Syst & Comp Engn Technol & Sci INESC TEC, Porto, Portugal
[4] Univ Porto, ICBAS Sch Med & Biomed Sci, UMIB Unit Multidisciplinary Res Biomed, Porto, Portugal
[5] ICBAS, ITR Lab Integrat & Translat Res Populat Hlth, Porto, Portugal
来源
INFORMATICS FOR HEALTH & SOCIAL CARE | 2025年
关键词
Peripheral arterial disease; physical exercise; smartphone application; adherence; acceptability; usability;
D O I
10.1080/17538157.2025.2465527
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
This study presents the development and assessment of a mobile application - the WalkingPAD app - aimed at promoting adherence to physical exercise among patients with Peripheral Arterial Disease (PAD). The assessment of adherence, acceptability, and usability was performed using mixed methods. Thirty-eight patients participated in the study with a mean age of 63.4 years (SD = 6.8). Thirty patients used the application for three months, responded to a semi-structured interview, and completed a task test and the System Usability Scale (SUS, ranging from 0 to 100). The application's adherence rate was 73%. When patients were asked about their reasons for using the app, the main themes that emerged were motivation, self-monitoring, and support in fulfilling a commitment. The average SUS score was 82.82 (SD = 18.4), indicating high usability. An upcoming version of the WalkingPAD app is expected to redesign both tasks - opening the app and looking up the walking history - which were rated as the most difficult tasks to accomplish. The new version of the WalkingPAD app will incorporate participants' comments and suggestions to enhance usability for this population.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] The effects of dietary flaxseed on cardiac arrhythmias and claudication in patients with peripheral arterial disease
    Rodriguez-Leyva, Delfin
    Rodriguez-Portelles, Ayelen
    Weighell, Wendy
    Guzman, Randolph
    Maddaford, Thane G.
    Pierce, Grant N.
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2019, 97 (06) : 557 - 561
  • [32] A Review of Exercise Protocols for Patients With Peripheral Arterial Disease
    Lefebvre, Kristin
    Cody, Crystal
    Longaker, Erika
    Mason, Jennifer
    Monaghan, Rebecca
    TOPICS IN GERIATRIC REHABILITATION, 2013, 29 (03) : 165 - 178
  • [33] Clinical impact of exercise in patients with peripheral arterial disease
    Novakovic, Marko
    Jug, Borut
    Lenasi, Helena
    VASCULAR, 2017, 25 (04) : 412 - 422
  • [34] Cilostazol Pharmacokinetics after Single and Multiple Oral Doses in Healthy Males and Patients with Intermittent Claudication Resulting from Peripheral Arterial Disease
    Steven L. Bramer
    William P. Forbes
    Suresh Mallikaarjun
    Clinical Pharmacokinetics, 1999, 37 : 1 - 11
  • [35] Benefits of Low-Intensity Pain-Free Treadmill Exercise on Functional Capacity of Individuals Presenting With Intermittent Claudication Due to Peripheral Arterial Disease
    Barak, Sharon
    Stopka, Christine Boyd
    Martinez, Coleen Archer
    Carmeli, Eli
    ANGIOLOGY, 2009, 60 (04) : 477 - 486
  • [36] β-Blockers in Patients With Intermittent Claudication and Arterial Hypertension Results From the Nebivolol or Metoprolol in Arterial Occlusive Disease Trial
    Espinola-Klein, Christine
    Weisser, Gerhard
    Jagodzinski, Annika
    Savvidis, Savvas
    Warnholtz, Ascan
    Ostad, Mir-Abolfazl
    Gori, Tommaso
    Munzel, Thomas
    HYPERTENSION, 2011, 58 (02) : 148 - 154
  • [37] Cost-Effectiveness of Cilostazol, Naftidrofuryl Oxalate, and Pentoxifylline for the Treatment of Intermittent Claudication in People With Peripheral Arterial Disease
    Meng, Yang
    Squires, Hazel
    Stevens, John W.
    Simpson, Emma
    Harnan, Sue
    Thomas, Steve
    Michaels, Jonathan
    Stansby, Gerard
    O'Donnell, Mark E.
    ANGIOLOGY, 2014, 65 (03) : 190 - 197
  • [38] Trimetazidine improves exercise performance in patients with peripheral arterial disease
    Vitale, Cristiana
    Marazzi, Giuseppe
    Pelliccia, Francesco
    Volterrani, Maurizio
    Cerquetani, Elena
    Spoletini, Ilaria
    Mercuro, Giuseppe
    Bonassi, Stefano
    Dall'Armi, Valentina
    Fini, Massimo
    Rosano, Giuseppe M. C.
    PHARMACOLOGICAL RESEARCH, 2011, 63 (04) : 278 - 283
  • [39] Increased endogenous nitric oxide production induced by physical exercise in peripheral arterial occlusive disease patients
    Arosio, E
    Cuzzolin, L
    De Marchi, S
    Minuz, P
    Degan, M
    Crivellente, F
    Zannoni, M
    Benoni, G
    LIFE SCIENCES, 1999, 65 (26) : 2815 - 2822
  • [40] The addition of evolocumab to maximal tolerated statin therapy improves walking performance in patients with peripheral arterial disease and intermittent claudication (Evol-PAD study)
    Clavijo, Leonardo C.
    Caro, Jorge
    Choi, Jongkyu
    Caro, Jorge A.
    Tun, Han
    Rowe, Vincent
    Kumar, S. Ram
    Shavelle, David M.
    Matthews, Ray V.
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2023, 55 : 52 - 56